Forum Institutional
How can we achieve a healthy China by 2030?
The China Edition of Global Health and Healthcare Strategic Outlook outlines how equity and public-private partnerships can reduce barriers in healthcare.
Helen Chen
Helen Chen is Global Sector Co-Head for Healthcare and Life Sciences for Asia Pacific and a Greater China Managing Partner of L.E.K. Consulting based in Shanghai. Helen was a member of L.E.K.’s Global Leadership Team from 2012 to 2016, and was named one of Consulting magazine’s Global Leaders in Consulting in 2019.
Helen has over 30 years of consulting and industry experience in the U.S. and Asia markets and has lived in China since 2000. She helps companies expand their presence in China and Asia, and leverages Asia’s innovation to improve their global businesses. For companies anchored in China and Asia, Helen advises on their drive to innovation and globalization.
Helen is a frequent speaker and author on the opportunities and issues in China’s healthcare and life sciences sectors. Her expert commentary has appeared in Bloomberg, Financial Times, The Wall Street Journal, Forbes Asia and the South China Morning Post, and in industry publications including BioCentury, In Vivo, Scrip and BioWorld.
Prior to joining L.E.K., Helen was an associate director of finance at Genentech (now Roche) and a sales planner at Abbott Laboratories (now Abbvie). Helen received her A.B. cum laude in applied mathematics from Harvard University.
Most Popular